NCL Method STE-3
Detection of Mycoplasma Contamination in Nanoparticle Formulations
Listed in Datasets | publication by group NCL Protocols
Version 1.0 - published on 11 Jun 2021 doi:10.17917/PHFP-8573 - cite this
Description
Mycoplasma is a microorganism that lacks a nucleus and a cell wall which makes it unaffected by many antibiotics. Nanoparticles submitted to the NCL may be subjected to testing for mycoplasma when deemed necessary. The types of nanoparticle formulations generally tested for mycoplasma contamination include those that incorporate a component derived from an animal or hybridoma cultures.
Content List
NCL_Method_STE-3_2020.pdf(PDF | 280 KB)
Cite this work
Researchers should cite this work as follows:
- Timothy Potter, Barry Neun, Marina Dobrovolskaia (2021). NCL Method STE-3. NCI Hub. doi:10.17917/PHFP-8573
Tags
NCL Protocols
This publication belongs to the NCL Protocols group.
When watching a publication, you will be notified when a new version is released.